SCHEMBL9008934

SCHEMBL9008934

CCCCCCCCCCCC(OP(=O)(O)OP(=O)(O)O)C(O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY2 P41231 4/20 0.57
▸ EHMT1 Q9H9B1 1/20 0.56
▸ P2RY1 P47900 4/20 0.53
▸ SRC P12931 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ P2RX1 P51575 1/20 0.53
▸ P2RX3 P56373 1/20 0.53
▸ P2RX4 Q99571 1/20 0.53
▸ P2RX2 Q9UBL9 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ DNPH1 O43598 1/20 0.52
▸ PRKAB2 O43741 1/20 0.52
▸ TRPM2 O94759 1/20 0.52
▸ LDHA P00338 1/20 0.52
▸ ADRB2 P07550 1/20 0.52
▸ FBP1 P09467 1/20 0.52
▸ ADORA1 P30542 1/20 0.52
▸ PRKAG1 P54619 1/20 0.52
▸ PRKAA2 P54646 1/20 0.52
▸ PDE4D Q08499 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9008963 1.00 P2RY2 (0.57) P2RY2EHMT1P2RY1SRCSMN1; SMN2
SCHEMBL8440946 0.86 P2RY2 (0.60) P2RY2P2RY1SRCSMN1; SMN2P2RX1
SCHEMBL230821 0.85 EHMT1 (0.63) P2RY2EHMT1P2RY1SRCSMN1; SMN2
SCHEMBL8435885 0.85 P2RY2 (0.62) P2RY2P2RY1SRCSMN1; SMN2P2RX1
SCHEMBL8441544 0.83 P2RY2 (0.64) P2RY2P2RY1SRCSMN1; SMN2P2RX1
SCHEMBL30211841 0.83 P2RY2 (0.59) P2RY2EHMT1P2RY1SRCSMN1; SMN2
SCHEMBL29126399 0.83 P2RY2 (0.59) P2RY2EHMT1P2RY1SRCSMN1; SMN2
SCHEMBL3164897 0.82 P2RY2 (0.65) P2RY2P2RY1SRCSMN1; SMN2P2RX1
SCHEMBL800850 0.82 P2RY2 (0.64) P2RY2P2RY1SRCSMN1; SMN2P2RX1
SCHEMBL8438661 0.82 P2RY2 (0.64) P2RY2P2RY1SRCSMN1; SMN2P2RX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0738274-A1 NOVEL NUCLEOSIDE-LIPID ADDITION COMPOUNDS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (DE) 1996-10-23 — — EP claimed
WO-1995018816-A1 NOVEL NUCLEOSIDE-LIPID ADDITION COMPOUNDS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE Max-Delbrück-Centrum für Molekulare Medizin (DE) 1995-07-13 — — WO claimed
EP-0738274-A1 NOVEL NUCLEOSIDE-LIPID ADDITION COMPOUNDS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (DE) 1996-10-23 — — EP disclosed
WO-1995018816-A1 NOVEL NUCLEOSIDE-LIPID ADDITION COMPOUNDS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE Max-Delbrück-Centrum für Molekulare Medizin (DE) 1995-07-13 — — WO disclosed
Send feedback